Showing results (121-130 of 152) with videos related to
Sort By:
Pageof 16
Cancer Research|May 1, 1988
Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivoT S Herman, B A Teicher, V Chan, et al.Cancer Research|February 1, 1991
Lonidamine as a modulator of alkylating agent activity in vitro and in vivoB A Teicher, T S Herman, S A Holden, et al.Clinical Cardiology|May 1, 1992
24-hour efficacy of once-daily diltiazem in essential hypertensionB M Massie, E Der, T S Herman, et al.Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Effect of a bovine hemoglobin preparation (SBHS) on the response of two murine solid tumors to radiation therapy or chemotherapeutic alkylating agentsB A Teicher, S A Holden, G Ara, et al.Journal of the National Cancer Institute|August 6, 1997
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomyJ A Talcott, P Rieker, K J Propert, et al.Cancer Gene Therapy|December 21, 2013
Abscopal effect of low-LET γ-radiation mediated through Rel protein signal transduction in a mouse model of nontargeted radiation responseS Aravindan, M Natarajan, S K Ramraj, et al.Seminars in Oncology|February 1, 1990
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combinationB A Teicher, S A Holden, J P Eder, et al.Cancer Research|September 1, 1981
Rate of heating as a determinant of hyperthermic cytotoxicityT S Herman, E W Gerner, B E Magun, et al.Journal of Clinical Pharmacology|April 1, 1992
Dose-dependent effects of betaxolol in hypertension: a double-blind, multicenter studyR L Williams, K K Goyle, T S Herman, et al.Cancer Research|September 15, 1988
Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant sublineT S Herman, B A Teicher, K N Cathcart, et al.Pageof 16